PL431268A1 - Kompozycja suplementu diety i/lub dodatku odżywczego do żywności, jednostkowa postać dawkowania tej kompozycji i ich zastosowanie do poprawy jakości widzenia w tym wrażliwości na kontrast u osób potrzebujących takiej poprawy, w tym osób cierpiących na co najmniej jedną chorobę oczu, zwłaszcza na męty szklistkowe - Google Patents

Kompozycja suplementu diety i/lub dodatku odżywczego do żywności, jednostkowa postać dawkowania tej kompozycji i ich zastosowanie do poprawy jakości widzenia w tym wrażliwości na kontrast u osób potrzebujących takiej poprawy, w tym osób cierpiących na co najmniej jedną chorobę oczu, zwłaszcza na męty szklistkowe

Info

Publication number
PL431268A1
PL431268A1 PL431268A PL43126819A PL431268A1 PL 431268 A1 PL431268 A1 PL 431268A1 PL 431268 A PL431268 A PL 431268A PL 43126819 A PL43126819 A PL 43126819A PL 431268 A1 PL431268 A1 PL 431268A1
Authority
PL
Poland
Prior art keywords
composition
dietary supplement
persons
improvement
dosage form
Prior art date
Application number
PL431268A
Other languages
English (en)
Inventor
John Nolan
Emmanuel ANKAMAH
Maciej OSĘKA
Robert KUCHLING
Original Assignee
ebiga-VISION GMBH
Osęka Maciej 4Eyez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ebiga-VISION GMBH, Osęka Maciej 4Eyez filed Critical ebiga-VISION GMBH
Priority to PL431268A priority Critical patent/PL431268A1/pl
Priority to EP20797888.3A priority patent/EP4033921B1/en
Priority to AU2020352751A priority patent/AU2020352751B2/en
Priority to PH1/2022/550633A priority patent/PH12022550633A1/en
Priority to RS20241197A priority patent/RS66108B1/sr
Priority to KR1020227013448A priority patent/KR20220108762A/ko
Priority to MA68118A priority patent/MA68118B1/fr
Priority to PCT/PL2020/050069 priority patent/WO2021061000A1/en
Priority to ES20797888T priority patent/ES2993253T3/es
Priority to CA3151619A priority patent/CA3151619C/en
Priority to MX2022003527A priority patent/MX2022003527A/es
Priority to US17/764,053 priority patent/US20220378075A1/en
Priority to CN202080067608.XA priority patent/CN114513971A/zh
Publication of PL431268A1 publication Critical patent/PL431268A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/063—Lysine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1642—Zinc
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/21—Plant extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/708—Vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Przedmiotem wynalazku jest kompozycja suplementu diety i/lub dodatku odżywczego do żywności, jednostkowa postać dawkowania tej kompozycji i ich zastosowanie do poprawy jakości widzenia w tym wrażliwości na kontrast u osób potrzebujących takiej poprawy, w tym osób cierpiących na co najmniej jedną chorobę oczu, zwłaszcza na męty szklistkowe. Kompozycja suplementu diety i/lub dodatku odżywczego do żywności zawiera w terapeutycznie skutecznych ilościach L-lizynę, witaminę C, cynk, ekstrakt z winogron i ekstrakt z pomarańczy gorzkiej jako substancje aktywne, i ewentualnie co najmniej jedną substancję pomocniczą. W korzystnym przykładzie wykonania tej kompozycji udziały procentowe poszczególnych substancji aktywnych względem sumy udziałów procentowych wszystkich substancji aktywnych wynoszą około 50% wag. L-lizyny, około 15% wag. witaminy C, około 2% wag. cynku, około 10% wag. ekstraktu z winogron i około 23% wag. ekstraktu z pomarańczy gorzkiej, przy czym wszystkie udziały procentowe poszczególnych substancji aktywnych sumują się do 100% wagowych wszystkich substancji aktywnych.
PL431268A 2019-09-25 2019-09-25 Kompozycja suplementu diety i/lub dodatku odżywczego do żywności, jednostkowa postać dawkowania tej kompozycji i ich zastosowanie do poprawy jakości widzenia w tym wrażliwości na kontrast u osób potrzebujących takiej poprawy, w tym osób cierpiących na co najmniej jedną chorobę oczu, zwłaszcza na męty szklistkowe PL431268A1 (pl)

Priority Applications (13)

Application Number Priority Date Filing Date Title
PL431268A PL431268A1 (pl) 2019-09-25 2019-09-25 Kompozycja suplementu diety i/lub dodatku odżywczego do żywności, jednostkowa postać dawkowania tej kompozycji i ich zastosowanie do poprawy jakości widzenia w tym wrażliwości na kontrast u osób potrzebujących takiej poprawy, w tym osób cierpiących na co najmniej jedną chorobę oczu, zwłaszcza na męty szklistkowe
EP20797888.3A EP4033921B1 (en) 2019-09-25 2020-09-24 Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
AU2020352751A AU2020352751B2 (en) 2019-09-25 2020-09-24 Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
PH1/2022/550633A PH12022550633A1 (en) 2019-09-25 2020-09-24 Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
RS20241197A RS66108B1 (sr) 2019-09-25 2020-09-24 Sastav dodatka ishrani i/ili nutritivnog dodatka za hranu, jedinični dozni oblik navedenog sastava, i njihova upotreba za poboljšanje kvaliteta funkcije vida, uključujući kontrasnu osetljivost kod osoba kojima je potrebno takvo poboljšanje uključujući osobe koje pate od bar jedne bolesti oka, naročito plutajućih mrlja u staklastom telu
KR1020227013448A KR20220108762A (ko) 2019-09-25 2020-09-24 식이 보충제 및/또는 식품용 영양 첨가제의 조성물, 이의 단일 투여량 형태, 및 적어도 하나의 안질환, 특히 비문증을 앓고 있는 사람을 포함하는, 사실상 대비 감도를 포함하는 시각적 성능 개선이 필요한 사람의 그러한 개선을 위한 이들의 용도
MA68118A MA68118B1 (fr) 2019-09-25 2020-09-24 Composition d'un complément alimentaire et/ou d'un additif nutritionnel pour aliments, forme posologique unitaire de ladite composition, et leur utilisation pour l'amélioration de la qualité de performance visuelle, y compris la sensibilité de contraste chez des personnes ayant besoin d'une telle amélioration, y compris des personnes souffrant d'au moins une maladie oculaire, en particulier le corps flottant du vitré
PCT/PL2020/050069 WO2021061000A1 (en) 2019-09-25 2020-09-24 Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
ES20797888T ES2993253T3 (en) 2019-09-25 2020-09-24 Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
CA3151619A CA3151619C (en) 2019-09-25 2020-09-24 Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
MX2022003527A MX2022003527A (es) 2019-09-25 2020-09-24 Composicion de un suplemento dietetico y/o un aditivo nutricional para alimentos, una forma de dosis unitaria de esta composicion y su uso para mejora de la calidad del rendimiento visual, incluida sensibilidad al contraste en personas en necesidad de esta mejora, incluidas personas que padecen al menos una enfermedad ocular, particularmente flotadores vitreos.
US17/764,053 US20220378075A1 (en) 2019-09-25 2020-09-24 Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
CN202080067608.XA CN114513971A (zh) 2019-09-25 2020-09-24 用于食品的膳食补充剂和/或营养添加剂的组合物、该组合物的单位剂型及它们在有需要改善的人，包括在至少一种眼疾病，尤其玻璃体飞蚊症的人中改善包括对比敏感度的视觉功能的用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL431268A PL431268A1 (pl) 2019-09-25 2019-09-25 Kompozycja suplementu diety i/lub dodatku odżywczego do żywności, jednostkowa postać dawkowania tej kompozycji i ich zastosowanie do poprawy jakości widzenia w tym wrażliwości na kontrast u osób potrzebujących takiej poprawy, w tym osób cierpiących na co najmniej jedną chorobę oczu, zwłaszcza na męty szklistkowe

Publications (1)

Publication Number Publication Date
PL431268A1 true PL431268A1 (pl) 2021-04-06

Family

ID=73030188

Family Applications (1)

Application Number Title Priority Date Filing Date
PL431268A PL431268A1 (pl) 2019-09-25 2019-09-25 Kompozycja suplementu diety i/lub dodatku odżywczego do żywności, jednostkowa postać dawkowania tej kompozycji i ich zastosowanie do poprawy jakości widzenia w tym wrażliwości na kontrast u osób potrzebujących takiej poprawy, w tym osób cierpiących na co najmniej jedną chorobę oczu, zwłaszcza na męty szklistkowe

Country Status (12)

Country Link
US (1) US20220378075A1 (pl)
EP (1) EP4033921B1 (pl)
KR (1) KR20220108762A (pl)
CN (1) CN114513971A (pl)
AU (1) AU2020352751B2 (pl)
ES (1) ES2993253T3 (pl)
MA (1) MA68118B1 (pl)
MX (1) MX2022003527A (pl)
PH (1) PH12022550633A1 (pl)
PL (1) PL431268A1 (pl)
RS (1) RS66108B1 (pl)
WO (1) WO2021061000A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102748966B1 (ko) 2024-05-31 2025-01-03 주식회사 상상바이오 유리체 변성 개선을 통해 망막박리 질환을 예방하여 비문증 개선에 도움을 주는 기능성 식품 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2023945T3 (pl) * 2006-06-08 2020-04-30 Iams Europe B.V. Kompozycja poprawiająca zdrowie oczu
US20080038367A1 (en) * 2006-08-11 2008-02-14 Sal Saloum Nutritional supplement compositions and methods of preparing
CN100587052C (zh) * 2006-10-17 2010-02-03 通化通久葡萄酒有限公司 Opc葡萄酒
US20100196577A1 (en) * 2009-02-03 2010-08-05 Tropicana Products, Inc. Microencapsulated citrus phytochemicals comprising citrus limonoids and application to sports drinks
US20110142766A1 (en) * 2009-12-16 2011-06-16 Sal Rafanelli Effervescent Multi-Vitamin Formulation and Methods of Use Thereof
CN101843784A (zh) * 2010-02-08 2010-09-29 崔晓廷 一种强效保护视力的多维叶黄素制剂
US20160151437A1 (en) * 2014-06-02 2016-06-02 Viva Pharmaceutical, Inc. Nutritional supplements for improved vision and methods of treating the same
CN107074884A (zh) * 2014-06-18 2017-08-18 西蒂斯制药有限责任公司 活性剂的矿物质氨基酸复合物
CN105832977A (zh) * 2016-03-11 2016-08-10 李仁山 一种护眼滋养液及其制备方法
JP6861955B2 (ja) * 2017-01-11 2021-04-21 日本メナード化粧品株式会社 ヒアルロン酸合成促進剤
CN108450722A (zh) * 2018-05-09 2018-08-28 青岛明眸健康科技有限公司 一种维生素功能饮料及其制备方法

Also Published As

Publication number Publication date
EP4033921B1 (en) 2024-08-14
RS66108B1 (sr) 2024-11-29
EP4033921A1 (en) 2022-08-03
AU2020352751A1 (en) 2022-04-07
US20220378075A1 (en) 2022-12-01
ES2993253T3 (en) 2024-12-26
AU2020352751B2 (en) 2023-08-17
MA68118B1 (fr) 2024-11-29
KR20220108762A (ko) 2022-08-03
PH12022550633A1 (en) 2023-03-27
CA3151619A1 (en) 2021-04-01
MX2022003527A (es) 2022-04-11
EP4033921C0 (en) 2024-08-14
WO2021061000A1 (en) 2021-04-01
CN114513971A (zh) 2022-05-17

Similar Documents

Publication Publication Date Title
WO2020033669A8 (en) Antagonists of t2r54 and compositions and uses thereof
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
RU2009101047A (ru) Способы и композиции для улучшения когнитивной функции
Tang et al. Effect of a mangosteen dietary supplement on human immune function: a randomized, double-blind, placebo-controlled trial
PH12017502181A1 (en) Nutritional compositions containing an elevated level of inositol and uses thereof
MX2018011991A (es) Composiciones para el cuidado bucal con una exhibicion de saborizante eficaz.
KR101635268B1 (ko) 후코이단을 함유하는 비장세포의 생존 및 기능 증진 효과를 가진 면역증강용 조성물
US20080050472A1 (en) Supplemental dietary composition including caffeine, taurine and antioxidant
EP4400098A3 (en) Co-amorphous forms of beta-lactoglobulin and a drug substance
PL431268A1 (pl) Kompozycja suplementu diety i/lub dodatku odżywczego do żywności, jednostkowa postać dawkowania tej kompozycji i ich zastosowanie do poprawy jakości widzenia w tym wrażliwości na kontrast u osób potrzebujących takiej poprawy, w tym osób cierpiących na co najmniej jedną chorobę oczu, zwłaszcza na męty szklistkowe
US20200214325A1 (en) Protein Supplement System
Waskiewicz et al. The use of vitamin supplements among adults in Warsaw: is there any nutritional benefit?
DE202007019158U1 (de) Vorrichtung zur Durchführung eines kosmetischen Verfahrens zur Beeinflussung der Haut
MX2024005028A (es) Metodos y composiciones para proporcionar un beneficio para la salud en un animal.
FR3073142B1 (fr) Formulation cosmetique
US20120225144A1 (en) Herbal Supplement Prepared From Geranium
US20120225142A1 (en) Herbal Supplement Prepared From Pelargonium Citronellum
SG10201807034XA (en) A pharmaceutical composition for improving or preventing progression of Chronic Kidney Disease
HUP0204209A2 (hu) Készítmények lipidmetabolizmus-rendellenességek és allergiás formák megelőzésére és/vagy kezelésére
PL438195A1 (pl) Odżywka do włosów
BR0316135A (pt) Uso de um produto alimentìcio cozido
FR3064479B1 (fr) Compositions cosmetiques comprenant une association d'ingredients et leurs utilisations
PL427449A1 (pl) Fitofarmaceutyk do stosowania doustnego, zawierający kompozycję biologicznie aktywnych składników pochodzących z jednej rośliny
PH12022552816A1 (en) Methods of increasing microvascular blood flow
JP5655901B2 (ja) 大麦若葉末とコラーゲンを含有する懸濁用組成物